🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nicholas O’Grady

Duke University

ORCID: 0000-0001-8711-7508

Also affiliated with Clinical Research Institute, Duke Medical Center, Duke University Hospital

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.3Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005
Top 4%
4.9DataRank
Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Papers

Driven by 7 papers — median percentile 72. Top paper: “Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies”.

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005
Top 4%
4.9DataRank
Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101312
N/A
0.442DataRank · unranked
18 citations

Julia Wulfkuhle, Denise M. Wolf, Lamorna Brown Swigart, Christina Yau, Nicholas O’Grady +22 more

PRoBE the cloud toolkit: finding the best biomarkers of drug response within a breast cancer clinical trial

JAMIA Open(2021)10.1093/jamiaopen/ooab038
Top 51%
0.346DataRank
Top 51%2 citations

David L. Gibbs, Kawther Abdilleh, Adam L. Asare, Smita Asare, Sara J. Venters +8 more

Cerebrospinal fluid proteome of patients with persistent pain and/or postpartum depression after elective cesarean delivery: An exploratory prospective cohort study

Journal of Clinical Anesthesia(2025)10.1016/j.jclinane.2025.111855
N/A
0DataRank · unranked
6 citations

Michael J. Devinney, Matthew W. Foster, Rachel A. Myers, Nicholas O’Grady, Ru‐Rong Ji +3 more

Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy: Results from the I-SPY 2 trial

Research Square(2023)10.21203/rs.3.rs-2588168/v1
N/A
0DataRank · unranked
0 citations

Douglas Yee, David A. Potter, Patricia Jewett, Christina Yau, Heather Beckwith +7 more

Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial

Breast Cancer Research and Treatment(2024)10.1007/s10549-023-07214-5
N/A
0DataRank · unranked
5 citations

Douglas Yee, David A. Potter, Patricia Jewett, Christina Yau, Heather Beckwith +7 more

Reduced lung fluid club cell secretory protein informs chronic lung allograft dysfunction risk

European Respiratory Journal(2025)10.1183/13993003.00182-2025
N/A
0DataRank · unranked
2 citations

Jeremy M. Weber, Megan L. Neely, Nicholas O’Grady, Francine L. Kelly, Rachel A. Myers +15 more